Mankind Pharma Limited (MANKIND.NS) NSE

2,244.40

+30.5(+1.38%)

Updated at January 14 03:30PM

Currency In INR

Valuation

Market Cap994.71B
Enterprise Value1.07T
P/E Ratio52.91
PEG Ratio-6.3
Price/Sales Ratio6.82
Price/Book Ratio6.06
Enterprise/Revenue7.4
Enterprise/EBITDA29.02

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.13
Operating Margin0.25

Management Effectiveness

Return On Assets0.06
Return On Equity0.13

Income Statement

Revenue122.07B
Revenue/Share328.93
Gross Profit87.18B
EBITDA30.18B
Net Income19.91B
Diluted EPS49.09

Balance Sheet

Total Cash31.05B
Total Cash/Share75.22
Total Debt83.69B
Total Debt/Equity0.55
Current Ratio1.14
Book Value Per Share376.22

Price History

52-Week Change-15.81
52-Week High2,754.7
52-Week Low2,090
Moving Average 50 Days2,218.17
Moving Average 200 Days2,415.99

Statistics

Average Volume441,599
Shares Outstanding412.81M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield0.04
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A